Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Fingerpaint Adds to New Business Team

SARATOGA SPRINGS, NY – Fingerpaint, a full-service marketing agency based in Saratoga Springs, NY, has added MacKenzie Jones to its new business team. Jones will be based in the agency’s Saratoga Springs office. Jones, a former Fingerpaint intern and recent graduate of George Mason University, works across all agency disciplines as she strategically targets new […]

Read More »

Genentech Throws Cancers in a Basket to Detect Tumors at Their Genetic Roots

A groundbreaking cancer study funded by Genentech Inc. found that siccing a drug on a specific genetic mutation — rather than at specific types of cancer — could work for some patients but not for others. Snuffing out tumors at their genetic roots — rather than chasing a cancer from organ to organ — has […]

Read More »

Six GlaxoSmithKline Researchers Found Phoundry Pharma

Research Triangle Park, N.C.-based Phoundry Pharmaceuticals, Inc. announced the completion of its first seed financing on Tuesday. The company raised $500,000, led by Pappas Ventures, and is planning a second tranche for another $500,000 in upcoming months, with hopes of moving to a Series A round.   The company was recently founded by six researchers […]

Read More »

Valeant Acquires Female Sex Drive Drug Maker Sprout for $1 Billion

Sprout Pharmaceuticals continues to remain atop the news cycles just days after the U.S. Food and Drug Administration (FDA) approved the first female sex-drive drug, Addyi. Today Canadian-based Valeant Pharma (VRX) announced it was acquiring the now Raleigh, N.C.-based company for $1 billion in cash, plus a share of future profits based upon the achievement […]

Read More »

Applied Genetic Surges on $1 Billion+ Eye Deal With Biogen

Gainesville, Fla.-based Applied Genetic Technologies Corporation (AGTC) announced yesterday that its collaboration with Biogen, Inc. has now closed. Originally announced on July 2, 2015, the deal has met all the conditions under the Hart-Scott-Rodino Antritrust Improvements Act of 1976 and is good to go.   The deal, announced in July, was a collaboration and licensing […]

Read More »

First trial targeting mutation, not cancer type, gives mixed results

A powerful skin cancer drug may also be effective against lung cancer and other types of malignancies, according to a novel study that focused on a gene mutation seen in many kinds of tumors. This sort of study is “the new wave,” said Dr. Otis Brawley, chief medical officer of the American Cancer Society, who […]

Read More »

Fisher Center Scientists Identify Protective Molecule That Could Lead to New Class of Alzheimer’s Medications

NEW YORK, Aug. 19, 2015 /PRNewswire-USNewswire/ — Today, the Fisher Center for Alzheimer’s Research Foundation is proud to announce they have funded a significant new finding through research conducted by Fisher Center scientists at The Rockefeller University in an effort to find a cure for Alzheimer’s. “I am so pleased to announce that with the […]

Read More »

Endometrial cancer on the rise in U.S., black women most at risk

Endometrial cancer is becoming more common in the U.S. and black women appear more likely to get the most aggressive types of tumors and die from the disease, a new study suggests. Researchers analyzed cancer registry data from 2000 to 2011 and found incidence rates for endometrial tumors increased among all racial and ethnic groups. […]

Read More »

H. Lundbeck Slashing 1,000 Employees as Company Faces Declining Revenue Due to Generic Competition

Approximately 1,000 jobs will be eliminated at H. Lundbeck A/S (LUN.CO) as the psychiatric drugmaker faces increased competition from generic medications, the Danish company announced this morning. Kåre Schultz, Lundbeck’s new chief executive officer, said the company’s new restructuring program will improve its fiscal position so it can “invest in future profitable growth initiatives.” Schultz, […]

Read More »

Buyer beware: some generic eczema creams pricier than others

Patients who try to save money by getting generic prescriptions for creams and ointments to treat skin conditions like eczema and psoriasis may face sticker shock at the pharmacy, a U.S. study suggests. Researchers compared the average co-payments, or out-of-pocket prices, for several commonly prescribed topical corticosteroids, which have been used for decades to treat […]

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!

Subscribe

Ad Right Bottom